Advertisement

Topics

United Therapeutics Corporation (UTHR) CEO Martine A. Rothblatt Sells 1,260 Shares

11:26 EST 14 Nov 2017 | Topix

United Therapeutics Corporation CEO Martine A. Rothblatt sold 1,260 shares of the stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $121.46, for a total transaction of $153,039.60.

Original Article: United Therapeutics Corporation (UTHR) CEO Martine A. Rothblatt Sells 1,260 Shares

NEXT ARTICLE

More From BioPortfolio on "United Therapeutics Corporation (UTHR) CEO Martine A. Rothblatt Sells 1,260 Shares"

Advertisement
Quick Search
Advertisement
Advertisement